Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Carrier screening of RTEL1 mutations in the Ashkenazi Jewish population.
Authors: Fedick AM,  Shi L,  Jalas C,  Treff NR,  Ekstein J,  Kornreich R,  Edelmann L,  Mehta L,  Savage SA
Journal: Clin Genet
Date: 2015 Aug
Branches: CGB
PubMed ID: 25047097
PMC ID: not available
Abstract: Hoyeraal-Hreidarsson syndrome (HH) is a clinically severe variant of dyskeratosis congenita (DC), characterized by cerebellar hypoplasia, microcephaly, intrauterine growth retardation, and severe immunodeficiency in addition to features of DC. Germline mutations in the RTEL1 gene have recently been identified as causative of HH. In this study, the carrier frequency for five RTEL1 mutations that occurred in individuals of Ashkenazi Jewish descent was investigated in order to advise on including them in existing clinical mutation panels for this population. Our screening showed that the carrier frequency for c.3791G>A (p.R1264H) was higher than expected, 1% in the Ashkenazi Orthodox and 0.45% in the general Ashkenazi Jewish population. Haplotype analyses suggested the presence of a common founder. We recommend that the c.3791G>A RTEL1 mutation be considered for inclusion in carrier screening panels in the Ashkenazi population.